are facing backlash for using the story of a deceased firefighter in a competition round where shamans were asked to predict his fate. In the series, South Korea’s “top 49 fate readers” – supposedly ...

Rehab Addict star Nicole Curtis has issued an apology for using the "N word" in shocking footage that was exclusively revealed by RadarOnline.comafter HGTV pulled the plug on her show. The 49-year-old ...

Bad Bunny's halftime show was a moment that was waited for by millions -- so much so that the "Benito Bowl," as it was lovingly coined by fans, had an impact on New Yorkers' bathroom ...

The infliction of injuries on Madison Mogen, Kaylee Goncalves and Xana Kernodle exceeded "the force necessary to cause death," a forensic pathologist tells PEOPLE Courtesy of Chapin Family; Maddie ...

Ask if you should, not if you could. Can. Could. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

The Rated Red Crew inspects Realtree’s new camo patterns at Shot Show and debates whether they blend or just look cool. Shooting at Rhode Island youth hockey game leaves 3 dead, including shooter, and ...

Finally, a way to prove to your LinkedIn followers that you’re proficient in vibe coding. LinkedIn announced a new partnership on Wednesday allowing users to display official certifications in AI ...

Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...

We may receive a commission on purchases made from links. Smart home gadgets have become so common that you or someone you know must own at least a few of these. It could be something as small as a ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...